Extracellular Vesicles in Mental Disorders: A State-of-art Review

Int J Biol Sci. 2023 Feb 5;19(4):1094-1109. doi: 10.7150/ijbs.79666. eCollection 2023.

Abstract

Extracellular vesicles (EVs) are nanoscale particles with various physiological functions including mediating cellular communication in the central nervous system (CNS), which indicates a linkage between these particles and mental disorders such as schizophrenia, bipolar disorder, major depressive disorder, etc. To date, known characteristics of mental disorders are mainly neuroinflammation and dysfunctions of homeostasis in the CNS, and EVs are proven to be able to regulate these pathological processes. In addition, studies have found that some cargo of EVs, especially miRNAs, were significantly up- or down-regulated in patients with mental disorders. For many years, interest has been generated in exploring new diagnostic and therapeutic methods for mental disorders, but scale assessment and routine drug intervention are still the first-line applications so far. Therefore, underlying the downstream functions of EVs and their cargo may help uncover the pathogenetic mechanisms of mental disorders as well as provide novel biomarkers and therapeutic candidates. This review aims to address the connection between EVs and mental disorders, and discuss the current strategies that focus on EVs-related psychiatric detection and therapy.

Keywords: Extracellular vesicle; biomarker; mental disorder; non-coding RNA.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System
  • Depressive Disorder, Major*
  • Extracellular Vesicles* / physiology
  • Humans
  • Mental Disorders*
  • MicroRNAs* / genetics

Substances

  • MicroRNAs